Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Joanna Chorostowska-Wynimko, Miriam Barrecheguren, Ilaria Ferrarotti, Timm Greulich, Robert A Sandhaus & Michael Campos. (2020) New Patient-Centric Approaches to the Management of Alpha-1 Antitrypsin Deficiency. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 345-355.
Read now
Read now
Kenneth R Chapman, Joanna Chorostowska-Wynimko, A Rembert Koczulla, Ilaria Ferrarotti & Noel G McElvaney. (2018) Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 419-432.
Read now
Read now
Alfonso Carleo, Joanna Chorostowska-Wynimko, Thomas Koeck, Harald Mischak, Małgorzata Czajkowska-Malinowska, Adriana Rozy, Tobias Welte & Sabina Janciauskiene. (2017) Does urinary peptide content differ between COPD patients with and without inherited alpha-1 antitrypsin deficiency?. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 829-837.
Read now
Read now
Articles from other publishers (16)
Joanna Chorostowska-Wynimko, A Rembert Koczulla & Maria Sucena. (2023) European pathways of care in Alpha-1 Antitrypsin deficiency. Respiratory Medicine 220, pages 107450.
Crossref
Crossref
Charlie Strange, N. Gerard McElvaney, Claus F. Vogelmeier, Marcos Marin-Galiano, Michaela Buch-Haensel, Xiang Zhang, Younan Chen, Oliver Vit, Marion Wencker & Kenneth R. Chapman. (2023)
The effect of exacerbations on lung density in α
1
-antitrypsin deficiency
. ERJ Open Research 9:2, pages 00457-2022.
Crossref
Crossref
Alvar Agusti, Nicolino Ambrosino, Felicity Blackstock, Jean Bourbeau, Richard Casaburi, Bartolome Celli, Gerard J. Criner, Rebecca Crouch, Roberto W. Dal Negro, Michael Dreher, Chris Garvey, Daniel A. Gerardi, Roger Goldstein, Nicola A. Hanania, Anne E. Holland, Antarpreet Kaur, Suzanne Lareau, Peter K. Lindenauer, David Mannino, Barry Make, François Maltais, Jeffrey D. Marciniuk, Paula Meek, Mike Morgan, Jean-Louis Pepin, Jane Z. Reardon, Carolyn L. Rochester, Sally Singh, Martijn A. Spruit, Michael C. Steiner, Thierry Troosters, Michele Vitacca, Enico Clini, Jose Jardim, Linda Nici, Jonathan Raskin & Richard ZuWallack. (2023) COPD: Providing the right treatment for the right patient at the right time. Respiratory Medicine 207, pages 107041.
Crossref
Crossref
Ronald van Vollenhoven, Anca D Askanase, Andrew S Bomback, Ian N Bruce, Angela Carroll, Maria Dall'Era, Mark Daniels, Roger A Levy, Andreas Schwarting, Holly A Quasny, Murray B Urowitz, Ming-Hui Zhao & Richard Furie. (2022) Conceptual framework for defining disease modification in systemic lupus erythematosus: a call for formal criteria. Lupus Science & Medicine 9:1, pages e000634.
Crossref
Crossref
Thais Ferrari da Cruz, Rogério Rufino, Agnaldo Lopes & Cláudia Henrique Costa. (2021) Small airway evaluation in three subjects with alpha-1 antitrypsin deficiency without diagnosed lung disease. BMJ Case Reports 14:3, pages e239146.
Crossref
Crossref
Yuh-Chin Tony Huang, Marion Wencker & Bastiaan Driehuys. (2021) Imaging in alpha-1 antitrypsin deficiency: a window into the disease. Therapeutic Advances in Chronic Disease 12_suppl, pages 204062232110245.
Crossref
Crossref
Igor Barjaktarevic & Michael Campos. (2021) Management of lung disease in alpha-1 antitrypsin deficiency: what we do and what we do not know. Therapeutic Advances in Chronic Disease 12_suppl, pages 204062232110101.
Crossref
Crossref
Ildikó Horváth, Maria Canotilho, Jan Chlumský, Joanna Chorostowska-Wynimko, Luciano Corda, Eric Derom, Joachim H. Ficker, Meinhard Kneussl, Marc Miravitlles, Maria Sucena, Gabriel Thabut, Alice M. Turner, Emily van ’t Wout & N. Gerard McElvaney. (2019)
Diagnosis and management of α
1
-antitrypsin deficiency in Europe: an expert survey
. ERJ Open Research 5:1, pages 00171-2018.
Crossref
Crossref
Timothy J. Craig & Maria Paula Henao. (2018)
Advances in managing COPD related to α
1
-antitrypsin deficiency: An under-recognized genetic disorder
. Allergy 73:11, pages 2110-2121.
Crossref
Crossref
Benedikt Schaefer, Mattias Mandorfer, André Viveiros, Armin Finkenstedt, Peter Ferenci, Stefan Schneeberger, Herbert Tilg & Heinz Zoller. (2018) Heterozygosity for the alpha‐1‐antitrypsin Z allele in cirrhosis is associated with more advanced disease. Liver Transplantation 24:6, pages 744-751.
Crossref
Crossref
Gabriel Thabut & Luciano Corda. (2018) Epidemiology, Diagnosis and Available Treatment for Alpha 1 Antitrypsin Deficiency-related Emphysema in Europe. European Respiratory & Pulmonary Diseases 4:1, pages 25.
Crossref
Crossref
Loukia M. Spineli, Eva Jenz, Anika Großhennig & Armin Koch. (2017) Critical appraisal of arguments for the delayed-start design proposed as alternative to the parallel-group randomized clinical trial design in the field of rare disease. Orphanet Journal of Rare Diseases 12:1.
Crossref
Crossref
Franck F. Rahaghi & Marc Miravitlles. (2017) Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence. Respiratory Research 18:1.
Crossref
Crossref
David J. Boerema, Bo An, Ronak P. Gandhi, Randy Papineau, Ed Regnier, Anna Wilder, Alexander Molitor, Andrew P. Tang & Scott M. Kee. (2017) Biochemical comparison of four commercially available human α 1 -proteinase inhibitors for treatment of α 1 -antitrypsin deficiency. Biologicals 50, pages 63-72.
Crossref
Crossref
Nalan DEMİR, Özlem ERÇEN DİKEN, Halil Gürhan KARABULUT, Demet KARNAK & Oya KAYACAN. (2017) Alpha-1 Antitrypsin Levels and Polymorphisms in Interstitial Lung Diseases. TURKISH JOURNAL OF MEDICAL SCIENCES 47, pages 476-482.
Crossref
Crossref
Mia Cahill. (2016) Modifying Alpha-1 Antitrypsin Deficiency-Related Emphysema: From Evidence to Practice. EMJ Respiratory, pages 35-42.
Crossref
Crossref